Bio-Rad Laboratories (BIO) vs Precipio (PRPO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Precipio (PRPO) has outperformed Bio-Rad Laboratories (BIO) over the past year, gaining 25.5% versus a gain of 24.1%. Over five years, BIO leads with a -49.0% price change compared with -54.1% for PRPO. Bio-Rad Laboratories is the larger company by market cap ($9.52 billion vs $41.5 million), about 229.4 times the size.
On valuation, Bio-Rad Laboratories trades at a lower forward P/E (35.9x vs 59.4x for Precipio).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIO | PRPO |
|---|---|---|
| Share price | $355.93 | $23.17 |
| Market cap | $9.52B | $41.48M |
| 1-day change | -3.26% | -1.49% |
| YTD return | +21.43% | +2.35% |
| 1-year return | +24.08% | +25.47% |
| 5-year return | -49.00% | -54.06% |
| P/E ratio (TTM) | 45.11 | — |
| Forward P/E | 35.89 | 59.41 |
| EPS (TTM) | $7.89 | $-0.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.58B | — |
| Revenue growth (YoY) | +0.65% | — |
| Net income (latest FY) | $759.90M | — |
| Gross margin | 51.87% | — |
| Operating margin | 1.83% | — |
| Net margin | 29.42% | — |
| 52-week high | $396.23 | $33.63 |
| 52-week low | $236.73 | $16.40 |
| Distance from 52-week high | -10.17% | -31.10% |
| Analyst consensus | hold | — |
| Avg. price target upside | -7.75% | — |
| Average volume | 276.93K | 128.13K |
| Shares outstanding | 21.68M | 1.79M |
| Employees | 7,450 | — |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bio-Rad Laboratories is about 229.4 times larger than Precipio by market value ($9.52B vs $41.48M).
About Bio-Rad Laboratories
BIO stock →Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 7,450 employees
BIO vs PRPO FAQ
Which is bigger, Bio-Rad Laboratories or Precipio?
Bio-Rad Laboratories (BIO) is larger, with a market capitalization of $9.52B compared with $41.48M for Precipio (PRPO).
Which stock has performed better over the past year, BIO or PRPO?
PRPO returned +25.47% over the past 12 months, compared with +24.08% for BIO (price return, excluding dividends). Past performance does not predict future results.
Are Bio-Rad Laboratories and Precipio in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.